Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies - PubMed (original) (raw)
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies
P T Nelson et al. Neurology. 2009.
Abstract
Background: Recent studies raised questions about the severity of cognitive impairment associated with dementia with Lewy bodies (DLB). However, there have been few analyses of large, multicenter data registries for clinical-pathologic correlation.
Methods: We evaluated data from the National Alzheimer's Coordinating Center registry (n = 5,813 cases meeting initial inclusion criteria) and the University of Kentucky Alzheimer's Disease Center autopsy series (n = 527) to compare quantitatively the severity of cognitive impairment associated with DLB pathology vs Alzheimer disease (AD) and AD+DLB pathologies.
Results: Mini-Mental State Examination (MMSE) scores showed that persons with pure DLB had cognitive impairment of relatively moderate severity (final MMSE score 15.6 +/- 8.7) compared to patients with pure AD and AD+DLB (final MMSE score 10.7 +/- 8.6 and 10.6 +/- 8.6). Persons with pure DLB pathology from both data sets had more years of formal education and were more likely to be male. Differences in final MMSE scores were significant (p < 0.01) between pure DLB and both AD+DLB and pure AD even after correction for education level, gender, and MMSE-death interval. Even in cases with extensive neocortical LBs, the degree of cognitive impairment was most strongly related to the amount of concomitant AD-type neurofibrillary pathology.
Conclusions: Dementia with Lewy bodies can constitute a debilitating disease with associated psychiatric, motoric, and autonomic dysfunction. However, neocortical Lewy bodies are not a substrate for severe global cognitive impairment as assessed by the Mini-Mental State Examination. Instead, neocortical Lewy bodies appear to constitute or reflect an additive disease process, requiring Alzheimer disease or other concomitant brain diseases to induce severe global cognitive deterioration.
Figures
Figure 1 Evaluation of average final antemortem MMSE scores for patients with and without appreciable neocortical LBs present according to Braak neurofibrillary stages on neuropathology reports Note that the presence of neocortical Lewy bodies (LBs) is associated with a relatively modest decrease in final Mini-Mental State Examination (MMSE) scores at some Braak stages. The University of Kentucky Alzheimer's Disease Center (UK ADC) data are shown separately from the National Alzheimer's Coordinating Center (NACC) Registry data because each study group has unique characteristics. For these figures, only cases with autopsies from 1999 to 2008 were used to ensure most up-to-date pathologic techniques. Statistically, the mean final MMSE scores were not different in Braak stage VI patients in the presence vs absence of neocortical LBs (using NACC Registry, UK ADC, or combining data). Error bars = standard deviation. MMSE scores vary by Alzheimer disease–type Braak staging and presence or absence of neocortical LBs.
Figure 2 Cognitive impairment is seen in some but not all patients with pure dementia with Lewy bodies confirmed at autopsy The rate of cognitive impairment for 9 individuals with pure dementia with Lewy bodies from the University of Kentucky Alzheimer's Disease Center database with 3 or more serial Mini-Mental State Examination (MMSE) scores. The abscissa refers to years before death.
Figure 3 Rate of cognitive deterioration in patients with autopsy-confirmed pure DLB, pure AD, or AD+DLB Analysis of last 4 Mini-Mental State Examination (MMSE) scores before death of persons from the University of Kentucky Alzheimer's Disease Center autopsy series with pathologically confirmed pure dementia with Lewy bodies (DLB; n = 9), pure Alzheimer disease (AD; n = 107), or AD+DLB (n = 27) was performed to determine how the average intercept and slope varied among the 3 neuropathologic diagnostic groups after adjusting for years of education. With the caveat that it is a small group, the pure DLB group had higher MMSE scores 4 visits before death compared to the other groups and declined less perceptibly than the AD+DLB group (see text for details).
Similar articles
- Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease.
Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM. Peavy GM, et al. Am J Geriatr Psychiatry. 2013 Jun;21(6):509-19. doi: 10.1016/j.jagp.2012.10.022. Epub 2013 Mar 13. Am J Geriatr Psychiatry. 2013. PMID: 23567425 Free PMC article. - Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.
Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. Ala TA, et al. J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):483-8. doi: 10.1136/jnnp.70.4.483. J Neurol Neurosurg Psychiatry. 2001. PMID: 11254771 Free PMC article. - Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. Peavy GM, et al. Parkinsonism Relat Disord. 2016 Oct;31:72-78. doi: 10.1016/j.parkreldis.2016.07.008. Epub 2016 Jul 21. Parkinsonism Relat Disord. 2016. PMID: 27475955 Free PMC article. - Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review. - Challenges in Predicting Cognitive Decline in Dementia with Lewy Bodies.
Tsamakis K, Mueller C. Tsamakis K, et al. Dement Geriatr Cogn Disord. 2021;50(1):1-8. doi: 10.1159/000515008. Epub 2021 Mar 29. Dement Geriatr Cogn Disord. 2021. PMID: 33780925 Review.
Cited by
- Effect of common neuropathologies on progression of late life cognitive impairment.
Yu L, Boyle PA, Leurgans S, Schneider JA, Kryscio RJ, Wilson RS, Bennett DA. Yu L, et al. Neurobiol Aging. 2015 Jul;36(7):2225-2231. doi: 10.1016/j.neurobiolaging.2015.04.006. Epub 2015 Apr 22. Neurobiol Aging. 2015. PMID: 25976345 Free PMC article. - Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.
Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT. Brenowitz WD, et al. J Alzheimers Dis. 2014;39(3):691-702. doi: 10.3233/JAD-131880. J Alzheimers Dis. 2014. PMID: 24270205 Free PMC article. - Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
Donaghy PC, Firbank MJ, Thomas AJ, Lloyd J, Petrides G, Barnett N, Olsen K, O'Brien JT. Donaghy PC, et al. Mov Disord. 2018 Jul;33(7):1130-1138. doi: 10.1002/mds.27403. Epub 2018 Apr 19. Mov Disord. 2018. PMID: 29672930 Free PMC article. - NEDD4-mediated HSF1 degradation underlies α-synucleinopathy.
Kim E, Wang B, Sastry N, Masliah E, Nelson PT, Cai H, Liao FF. Kim E, et al. Hum Mol Genet. 2016 Jan 15;25(2):211-22. doi: 10.1093/hmg/ddv445. Epub 2015 Oct 26. Hum Mol Genet. 2016. PMID: 26503960 Free PMC article. - University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.
Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ, Caban-Holt A, Lovell MA, Kryscio RJ. Schmitt FA, et al. Curr Alzheimer Res. 2012 Jul;9(6):724-33. doi: 10.2174/156720512801322591. Curr Alzheimer Res. 2012. PMID: 22471862 Free PMC article.
References
- McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863–1872. - PubMed
- McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113–1124. - PubMed
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388:839–840. - PubMed
- Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045–2047. - PubMed
Publication types
MeSH terms
Grants and funding
- K08 NS050110/NS/NINDS NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- R01 NS061933-01A1/NS/NINDS NIH HHS/United States
- R01 NS061933/NS/NINDS NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- K08 NS050110-01/NS/NINDS NIH HHS/United States